OIS QUEBEC, EXPLORING OPTIMAL RESPONSE TO PUBLIC HEALTH EMERGENCIES
Outbreak Intervention - The White Paper Documentary
QUEBEC CITY, AN INTERNATIONAL HUB OF RESEARCH AGAINST INFECTIOUS DISEASES AND EMERGING PATHOGENS
OCTOBER 18TH & 19TH
2017 QUEBEC OIS
This two-day symposium will explore the ‘optimal’ response to public health emergencies and outbreak interventions. Focusing on emerging and re-emerging infectious diseases and high consequence pathogens, the symposium will determine how best to position and translate cross-sectorial technical expertise for high value impact in responding to key threats to public health globally.
ABOUT THE PROGRAM OF ACTIVITIES
Building on the success of the inaugural meeting in 2016, this year’s symposium draws on experiences from recent and ongoing outbreaks including Cholera in Yemen and the Horn of Africa, Ebola in the Democratic Republic of Congo, Yellow Fever in Angola and Brazil. The Symposium aims to drive forward discussions regarding the operationalization of an optimal response in the context of complex geopolitical and biosecurity agendas, and challenges the global health community to develop collaborations that enable it to be better prepared to move swiftly and effectively in emergencies. One focus of the 2017 event will be to explore strategies to help promote an inclusive and coordinated approach by international actors with respect to the national autonomy of affected countries.
The symposium brings together international experts from a range of disciplines including research and development, virology, clinical medicine, epidemiology, anthropology, social-behavioural science, urban development, health financing and emergency operations.
Québec city is an international hub of research in infectious diseases and emerging pathogens. The symposium’s steering committee is led by Gary Kobinger, Director of the Infectious Disease Research Centre at Université Laval, and Juliet Bedford, Director of Anthrologica. The advisory board includes Amanda McClelland (IFRC), Armand Sprecher (MSF), Doug Webb (UNDP), Laurent Kaiser (HUGs) and Brian Ward (McGill University).The symposium is supported by a non-conditional grant from Medicago.
Agenda of 2017 Quebec OIS Recap of 2017 Quebec OIS
2016 QUEBEC OIS
Policy makers and influences in the area of global health.
One of the first meetings of its kind where people with different expertise in outbreak response are all here.
Like-minded colleagues who work in the same space of a response but from very different angles.
This is where major solutions around inequalities in health will get answered.
Daniel Bausch is the Director of the United Kingdom Public Health Rapid Support Team (UK PHRST), a joint effort by Public Health England and the London School of Hygiene and Tropical Medicine to respond and conduct research to prevent and control outbreaks of dangerous infectious diseases around the world. He is trained in internal medicine, infectious diseases, tropical medicine, and public health. Dr. Bausch specializes in the research and control of emerging tropical viruses, with over 20 years’ experience in sub-Saharan Africa, Latin America, and Asia combating viruses such as Ebola, Lassa, hantavirus, and SARS coronavirus. He places a strong emphasis on capacity building in all his projects and also has a keen interest in the role of the scientist in promoting health and human rights.
Juliet Bedford is the Founder and Director of Anthrologica. Anthrologica is a leading international research organisation specialising in applied anthropology in global health, conducting formative and operational research at the interface between the provision and uptake of health services (www.anthrologica.com).
Juliet has over fifteen years technical experience in developing contexts, fragile states and emergency settings and has worked intensively across Africa, South and Southeast Asia. She holds a Doctorate in Anthropology from the University of Oxford, where she is a Research Associate at the Institute of Social and Cultural Anthropology, and is an Adjunct Professor at the College of Global Public Health at New York University.?
Miles Carroll joined Public Health England as Deputy Director, Head of Research at Porton Down in September 2008. In his current role he is responsible for > 250 scientists and support services personnel. He also has strategic and operational control to ensure that the Department is at the forefront of translational research in the areas of emerging diseases, diagnostics and decontamination, host pathogen interactions, infectious disease vaccines and therapeutics. His current personal research portfolio includes: naturally acquired immunity to EBOV, understanding the host response to infection, development of emerging disease vaccines and the development and application of molecular epidemiology.
Miles gained his PhD from the Medical Faculty at the University of Manchester which enabled him to obtain an International Fogarty Fellowship and continue his studies on recombinant poxviruses at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. On his return to the UK, Miles Joined Oxford Biomedica as Vice President of Immunotherapy. At OBM Miles invented the cancer vaccine, TroVax and led the pre-clinical and Phase II development programme.
Miles has authored ~100 publications primarily in the fields of recombinant vaccines and host pathogen interactions, and is the recipient of >15 granted patents. He has served as an advisor to the commercial life sciences sector, appeared as an expert witness in European and US patent cases. Miles currently serves on several Scientific Advisory Boards including the Animal and Plant Health Agency and Defence Science and Technology Laboratories. Miles is honorary Professor of Vaccinology at the Medical Faculty of the University of Southampton.
Director, Agriculture and Environment
As Director of IDRC’s Agriculture and Environment program, Dominique Charron oversees research that seeks innovative, evidence-based solutions to help people face the world’s toughest development and environmental challenges: poor agricultural productivity; food insecurity and malnutrition; chronic and infectious diseases; and, risks to lives and livelihoods from a changing climate. In this role, she pursues IDRC’s tradition of research excellence, the active involvement of stakeholders in the research process, including affected communities, and the integration of research outcomes into policy decisions that help improve the lives of all members of society.
Dr Charron joined IDRC in 2006 as Program Leader of the Ecosystems and Human Health program. Previously, Dr Charron developed and managed research programs on climate change and infectious diseases at the Public Health Agency of Canada. She has conducted research in Canada, including in the Arctic, and in the Caribbean. Dr Charron has taught epidemiology and ecosystem health at the graduate and undergraduate levels at several Canadian universities. She holds a PhD in epidemiology and a Doctor of Veterinary Medicine from the University of Guelph.
Directrice, Agriculture et environnement
À titre de directrice du domaine de programme Agriculture et environnement, Dominique Charron veille au bon déroulement d’activités de recherche ayant pour but de fournir des solutions innovantes et fondées sur des données probantes pour aider les personnes à faire face aux défis mondiaux les plus difficiles. Ces défis sont notamment la faible productivité agricole, l’insécurité alimentaire et la malnutrition, les maladies chroniques et infectieuses, et les risques pour la vie et les moyens de subsistance découlant des changements climatiques. Dans ce rôle, elle poursuit la tradition d’excellence du CRDI en recherche, prônant la participation active de la collectivité et de divers intervenants aux travaux de même que l’intégration des résultats de la recherche dans les politiques afin d’en maximiser les répercussions et d’améliorer concrètement la vie de tous les membres de la société.
Avant d’entrer au service du CRDI, en 2006, à titre de chef du programme Écosystèmes et santé humaine, Dr Charron était chargée de l’élaboration et de la gestion de programmes de recherche portant sur les changements climatiques et les maladies infectieuses, à l’Agence de la santé publique du Canada. Elle a mené des recherches au Canada, notamment dans l’Arctique, ainsi que dans les Caraïbes. Elle a donné des cours de premier, deuxième et troisième cycle en épidémiologie et salubrité des écosystèmes dans plusieurs universités canadiennes. Dr Charron est titulaire de deux doctorats, l’un en épidémiologie et l’autre en médecine vétérinaire, obtenus de l’Université de Guelph.
Marie-Christine started to work with MSF first in long term projects focusing on child and maternal health in Chad and Mali. She was during few years responsible of the support for vaccinations programs at HQ level in Brussels. Since 1988 Marie-Christine has been involved in the response to numerous complex emergencies including armed conflicts, natural disasters and various epidemics. She has worked as emergency field coordinator in numerous countries across Africa, Asia and Europe.
Marie-Christine was involved in the first MSF response to an Ebola outbreak, in Kikwit in 1995. Since than she has participated in the development of the MSF Ebola knowledge/experience ? through different outbreaks in Gabon, DRC, Sudan, Uganda and east Africa.
For more than 8 years Marie-Christine is the head of the emergency unit in MSF in Brussels. She is supporting field teams from the evaluation of the needs to the implementation of the adapted activities and evaluation of the response in order to improve the next response through the different lessons learnt.
Henry is an emergency medicine and public health doctor by background, and has been involved in a range of complex emergencies involving armed conflict and infectious disease. His training and service in the Royal Marines, as well as his work in the application of advanced technology provides a unique perspective on meeting the challenges that health emergencies present to us.
Prof. Antoine Flahault MD, PhD in biomathematics. He has been appointed as full professor of public health at Paris in 2002. He was the founding director of the French School of Public Health (EHESP, Rennes, 2007-2012). He is co-director of Centre Virchow-Villermé for Public Health Paris-Berlin (Université Descartes, Sorbonne Paris Cité), co-director of the European Academic Global Health Alliance (EAGHA), president of the Agency for Public Health Education Accreditation (APHEA).
He has conducted his research in mathematical modelling of communicable diseases; has chaired the WHO collaborative centre for electronic disease surveillance ; has coordinated research on Chikungunya in Indian Ocean (Inserm Prize, 2006; was scientific curator of a large exhibition Epidemik, la Cité des Sciences et de l’Industrie (Paris, Rio and Sao Paulo). In January 2014, he has been appointed as professor of public health at School of Medicine, University of Geneva where he is the founding director of the Institute of Global Health. He was elected corresponding member at Académie Nationale de Médecine (Paris). Last January 2014, he had more than 235 scientific publication referenced in Medline.
Sherine Guirguis is a public health and communications expert with over 15 years of international experience. She believes in positive disruption for social change, and has recently established Common Thread - a behavioral insights company for public health - to do just that. Sherine was recently in charge of UNICEF's global behavior change strategy for Polio Eradication, where she helped secure global public commitment for oral polio vaccine so the world could finally become polio-free. She was part of UNICEF’s senior team helping to end the 2014 Ebola Outbreak in West Africa, and was part of the local team in India that contributed to the last polio case in 2011. She has helped Maldivian communities recover from the Tsunami of 2004 and has supported numerous countries to develop communication and development strategies for positive change. She is widely published in the realm of public health and behavioral science. She speaks Arabic and holds a MSc from the London School of Hygiene and Tropical Medicine, and a MA from the Johns Hopkins School of Advanced International Studies. She is currently based in Bucharest, Romania.
For more than 6 years, Myriam worked in field positions with MSF in several countries in Africa and Asia. After completing an MPH at Johns Hopkins University, Myriam became the director of the medical department at MSF in Brussels and is now in charge of MSF’s international medical coordination. Besides coordinating the medical departments of all MSF sections, Myriam continues to be involved in several medical topics such as meningitis, cholera, vaccination, including outbreak responses and prevention in humanitarian settings; etc.
Myriam represents MSF at several interagency platforms such as the International Coordination Group for meningitis, yellow fever and cholera, among others. She has also been invited as an expert to several platforms on cholera vaccines, the WHO Essential Medicines List, etc.
Myriam is currently the leader of MSF intersection team for the quality assurance of medicines, medical devices including diagnostic tests, and therapeutic food. She represents MSF in related international platforms
Myriam is also a member of the GOARN steering committee.
Kaltun Hussen Daher has field experience in primary health care management, and she has been working with the Somali Red Crescent Society for 18 years as National Health and Nutrition Coordinator.
Her duties include planning and coordinating the SRCS Health Project at the national, regional and district levels; supervising and monitoring SRCS supported clinics in all regions of Somaliland; organizing and facilitating training for both medical staff and community resource persons; monthly collection of data from all SRCS managed clinics; quarterly compiling, analyzing and interpreting of data; timely distribution of analyzed and interpreted data to the respective partners and beneficiaries through workshops and electronic media
Prior to this position, Kaltun was Director of the Borama General Hospital for 4 years. She has given a vast amount of trainings and workshops for her colleagues and community members, including Community Resource Persons training, drug management, cases, EPI, management, midwifery training and CBHFA in action.
L. Kaiser is professor of medicine at the University of Geneva, Faculty of Medicine, Head of the Division of Infectious Diseases and Director of the Laboratory of Virology at the Geneva University Hospitals. The Division covers the full spectrum of infectious diseases encountered in a university teaching hospital. Highly specialized consultants each have a specific expertise in different fields, including HIV, infection in transplant recipients, osteoarticular infections, antibiotic stewardship, as well as clinical microbiology.
The laboratory of virology provides a panel of highly specialized tests. The goal is to integrate new technologies and new diagnostic assays to clinical care whenever this is relevant for patients or public health. The virology research team conducts clinical and diagnostic investigations, in different fields of virology, mainly focusing on hospitalized patients or transplant recipients. We address diagnostic and clinical issues in the field of respiratory viruses and other relevant viral diseases. The laboratory functions also as the Swiss reference centers for influenza and emerging viral diseases, and was involved in the 2014-2015 Ebola crises, among others. In collaboration with basic research groups we promote translational research on respiratory viruses and picornaviruses.
Gary Kobinger is a professor in the Department of Microbiology and Infectious Diseases and the Director of the Research Centre on Infectious Diseases, Faculty of Medicine at Université Laval. He is also an adjunct professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania, and an associate professor in the Department of Medical Microbiology at the University of Manitoba. His work focuses on developing and testing new vaccine platforms and immune treatments against emerging and re-emerging viruses of high consequences to public health.
Gary was granted several awards including the Faculty Teaching Award from the University of Manitoba, the 2014 the Gully award, the 2015 scientists of the year award from Radio Canada (CBC) and the Order of Manitoba in 2016.
Between 2013-2016, 60 minutes, National Geographic, BBC Horizon, NOVA, France 2, PBS and others featured the leading work on successful treatment of Ebola infection that was developed by Gary and his team. In July 2016, Gary Kobinger initiated a new chapter of his career as the Director of the Centre de Recherche en Infectiologie de l’Université Laval.
Shelley is a medical anthropologist. Over the past 20 years much of the focus of her research has been on gender and health in Tanzania. She is currently conducting anthropological research on violence against women and children with a number of different projects in Tanzania, one of which looks at the intersection between the prevention of HIV and the prevention of violence. Drawing on her experience of conducting anthropological research in an HIV prevention clinical trial, she is leading on anthropological research on two Ebola vaccine trials (EBOVAC and PREVAC) in Sierra Leone. She has an interest in the engagement of social scientists in future disease outbreaks and is conducting research to understand how this engagement can be effectively utilised and how best to engage with local communities about clinical trials and outbreaks.
Nicole Lurie, M.D., M.S.P.H. is currently a consultant for the World Bank and the Coalition for Epidemic Preparedness Initiatives (CEPI), and the World Health Organization, serves on the research faculty at Massachusetts General Hospital and Harvard Medical School. She recently completed an 8-year term as Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services. In that role she led the HHS response to numerous public health emergencies, ranging from infectious disease to natural and man-made disasters and is responsible for many innovations in emergency preparedness and response. She also chaired the Public Health Emergency Medical Countermeasures Enterprise, a government wide organization ultimately responsible for the development of medical countermeasures, including vaccines against pandemics and emerging threats. Following that, she served as Senior Advisor to the Director of the Indian Health Service, where she worked on issues related to quality of care. Prior to federal service, she was the Paul O'Neill Professor of Policy Analysis at RAND, where she started and led the public health preparedness program and RAND's Center for Population Health and Health Disparities. She has also had leadership roles in academia, as Professor of Medicine and Public Health at the University of Minnesota, as Medical Advisor to the Commissioner, Minnesota Department of Health, and as Principal Deputy Assistant Secretary for Health at the US Department of Health and Human Services. Dr. Lurie received her BA and MD degrees from the University of Pennsylvania, and completed her residency and public health training at UCLA. Her research has focused on access to and quality of care, health system redesign, equity, mental health, public health and preparedness. She is recipient of numerous awards and is a member of the National Academy of Medicine. She continues to practice clinical medicine in a community clinic in Washington DC.
Craig Manning began his public health communications career at the World Health Organisation (WHO), working first with the Communicable Disease Surveillance group and later with WHO’s immunisation and HIV/AIDS programmes.
From 2007 to 2017, Craig served as Health Communication Specialist in CDC’s Viral Special Pathogens Branch, traveling extensively and working with virologists, epidemiologists, behavioral scientists, and others from many agencies and organizations before, during, and after outbreaks of Ebola, Marburg, Rift Valley fever, hanta, Lassa, and LCM viruses in varying settings. During the West Africa Ebola outbreak, he led CDC’s Health Promotion teams in Guinea, Sierra Leone, and Liberia.
He has also worked with MSF and UNHCR on development of health communication materials.
Amanda is a Registered Nurse with 12 years of international experience. Starting her career as a Hygiene Promoter in South Sudan she has worked in numerous countries across Asia, the Pacific and Africa.
In her current role as Public Health in Emergencies Senior Advisor for the International Federation of the Red Cross and Red Crescent Societies she supports local teams in natural disasters and epidemics. She played a key role in the recent West Africa Ebola crisis working in Guinea, Liberia and Sierra Leone supporting the local National Societies in social mobilisation, Safe and Dignified Burial and clinical teams throughout the response. She continues to work on recent issues such as Zika and Yellow Fever focussing on improving the role of communities and local actors in epidemic preparedness detection and response.
Captain Jennifer McQuiston serves as the Deputy Director in the Division of High Consequence Pathogens and Pathology Science in the Centers for Disease Control and Prevention (CDC). Dr. McQuiston joined CDC in 1998 as an Epidemic Intelligence Service (EIS) Officer, conducting research and the investigation of outbreaks related to zoonotic diseases. Her past positions at CDC have included Epidemiology Team Lead for Rickettsial Diseases (2007-2014) and Science Advisor for Public Affairs (2014-2015) within the Office of the Associate Director for Communications. She served as CDC’s team lead for Health Communications in Sierra Leone during the 2014-2016 Ebola response, and during 2016 she served as the Deputy Incident Manager for CDC’s Zika response.
Prof Jean-Jacques Muyembe-Tamfum is a leading medical scientist in Democratic Republic of Congo (DRC) in the field of viral emerging and reemerging diseases and was appointed dean of the Faculty of Kinshasa University Medical School in 1976-1981.
In 1985 he served as vice-chairman of the WHO workshop held at Bangui (Central African Republic) on the African AIDS definition and during a WHO’s mission conducted in 1996, he provided the first assessment of the alarming HIV/AIDS prevalence in Kampala, Uganda. In 1978-1986 he was actively involved in the surveillance/ investigation of human Monkeypox infection (MPX) throughout the DRC and the training of healthcare workers in collaboration with international teams (WHO, CDC).
Since 1998 he has been the Director of the National Institute for biomedical Research (INRB) and chief of the WHO/National Polio and Measles laboratories in charge of biological surveillance of Acute Flaccid Paralysis (Poliomyelitis) and Measles/Yellow Fever for both DRC and Republic of Congo (Brazzaville).
His main scientific field of interest is Ebola hemorrhagic fever (clinical, laboratory and epidemiological aspects including control measures) since he was the first scientist to investigate the disease in Yambuku catholic mission in 1976. Since then, he has been involved in several Ebola outbreaks in DRC and neighboring countries as the chairman of the international scientific and technical coordination committee including the Kikwit Ebola outbreak, DRC (1995), Mayibout, Gabon (1996), Makokou, Gabon, and Mbomo, Congo (2000). He was also involved in the control of Ebola outbreaks in Mweka (2007), Kaluamba (2008) Isiro (2912), and Boende (2014) in DRC. He was the head of the delegation of the Congolese Ebola experts who were sent to Liberia by the President Kabila to help control the Ebola Disease Outbreak in this country in 2014.
In 2014 served as a scientific advisor to WHO/Geneva as part of the International Health Regulation (IHR) Emergency Committee on Ebola; Informal group on the Ebola virus Disease response, and Member of Ebola science Committee. He has authored more than 100 scientific papers in peer reviewed journals. Prof Muyembe has received several distinguished awards including a Lifetime Achievement Award for Excellence in Filovirus Research (2015), the Christophe Mérieux Prize (2015) and the Royal Society Pfizer Advanced Award (2015).
Dr Peter Salama, a medical epidemiologist from Australia, has served as Executive Director of the Health Emergencies Programme since 2016. Before joining WHO, Dr. Salama was UNICEF’s Regional Director for the Middle East and North Africa. Prior to these recent assignments, Dr Salama led UNICEF’s global response to Ebola, served as UNICEF Representative in Ethiopia and Zimbabwe (2009-2015), UNICEF’s Chief of Global Health and Principal Advisor on HIV/AIDS based at UNICEF headquarters in New York (2004-2009), and UNICEF’s Chief of Health and Nutrition in Afghanistan (2002-2004). Prior to joining UNICEF in 2002, Dr Salama was visiting scientist at the International Emergency and Refugee Health Branch at the US Centers for Disease Control (CDC), and a visiting professor in nutrition at Tufts University. He has also worked with Doctors without Borders and Concern Worldwide in several countries in Asia and sub-Saharan Africa.
Dr Salama has led research and published extensively on maternal and newborn child health, vaccine-preventable diseases, HIV, nutrition, war-related mortality and violence, refugee and emergency health, and programming in fragile states. He completed his medical and public health degrees at Melbourne and Harvard Universities, where he was also a Fulbright and Harkness fellow in public policy.
Dr Amadou A Sall is the CEO of Institut Pasteur de Dakar in Senegal and the chairman of the Global Outbreak Alert and Response Network and director of the WHO collaborating center for Arboviruses and viral hemorrhagic fever. Dr Sall is a virologist with a PhD in Public health. From 2002-2004, Dr Sall has worked in Cambodia as the head of viral hepatitis B at Institut Pasteur Cambodia. In 2010-2011, he works as a Visiting Research Scientist at the Center for Infection and immunity at the Mailman School of Public health at Columbia University of New york on pathogen discovery. Dr Sall is an expert in epidemics response and control more specifically for arboviruses and viral hemorrhagic fevers (Ebola, Zika, Yellow fever…). He is member several expert groups for WHO, OIE and scientific advisory board (CEPI, Institut Pasteur International Network). He has worked, taught and been consultant in Europe, Asia, Africa and America.
Jonathan Shadid has worked and lived in West Africa for over 30 years. His work in the region has been mostly dedicated to advocacy, social & behavior change and visual media. Since 2011, he has been working in Senegal with UNICEF, West & Central Africa Regional Office (WCARO) and focusing mostly on immunization behavior and social change interventions, emergency response (Ebola, yellow fever, Meningitis A, Measles), advocacy, alliance building, and crisis communications.
Armand is an emergency physician and epidemiologist who has worked with MSF since 1997. He has been involved with filovirus outbreak response since 2000, including working in the field during the outbreaks in Uganda 2000, Angola 2005, the Democratic Republic of the Congo in 2007, and the outbreak in West Africa. Between outbreaks, aside from filovirus disease issues, Armand works mostly on health informatics. Armand has also worked with the International Medical Corps and the CDC's Epidemic Intelligence Service
Born in California, Tommy is currently assigned to WFP Headquarters in Rome, as Chief of Readiness in the Emergency Division – responsible for the early actions in response to major global humanitarian emergencies.
Tommy started his career with WFP in 1993. While crossing the Sudan on route to Eritrea, as part of his round the world bicycle cycle tour. He took an unexpected break to help WFP run humanitarian assistance barges down the Nile and support the air drop operations in the context of Sudan’s long civil war. Tommy stayed with WFP Sudan logistics for the next 5 years, reassigning to Ethiopia as head of the Mek'ele sub-office in 1998, this time in the context of the conflict between Eritrea and Ethiopia.
In 2002 Tommy took over logistics operations in Somalia as Head of Logistics and Head of the UN Common Air Service. He also headed emergency logistics operations in Banda Aceh, Indonesia following the devastating 2005 Tsunami. He then returned to South Sudan to lead a comprehensive road building and de-mining operation to improve the infrastructure in one of the world’s least accessible nations.
In 2010 he took over the Global Logistics Cluster Coordinator role in WFP headquarters in Rome Italy. Tommy deployed to emergency field operations many times during his tenure. Recently as a WFP Emergency field coordinator in South Sudan, Logistics Coordinator in the Philippines after Typhoon Haiyan, and in West Africa as part of the Ebola response management team. His last assignment had been to WFP Bangkok, Thailand serving as the senior supply chain Advisor to the regional WFP office.
Dr. Ron Waldman has been a leading figure in global health for almost four decades. After serving as a volunteer in the WHO Global Smallpox Eradication Program, he joined the US Centers for Disease Control and Prevention as an EIS officer in the Michigan Health Department in 1979. While there, in addition to conducting seminal studies that established the link between aspirin and Reye Syndrome, he served intermittently in Somalia, helping to establish that country’s Refugee Health Unit. This experience led to studies on the health of large refugee populations and to a career-long interest in the study and promotion of humanitarian public health interventions in emergency-affected populations. A series of publications analyzing trends and outcomes in health and nutrition helped inject public health science into the field of humanitarian relief and many of his findings have become standard elements of practice. He remained active in the global public health emergency arena, serving in Iraq, the Balkans, the relief effort that followed the 1994 Rwanda genocide, and Afghanistan. More recently, he served as US Government coordinator of the health sector response following the Haiti earthquake in 2010 and as Senior Advisor to the UN during the Pakistan floods of the same year. He was Senior Technical Advisor to Save the Children during the 2014 West Africa Ebola outbreak. Outside of emergencies, he has served as Coordinator of the Cholera Task Force at WHO and as Technical Director of the USAID flagship child survival project, BASICS. In 1999, Waldman became Founding Director of the Program on Forced Migration and Health at the Mailman School of Public Health of Columbia University and in 2013 joined the faculty at the Milken Institute School of Public Health of George Washington University where he is currently helping to build an academic track in Public Health in Humanitarian Settings. In addition, he is currently Chairman of the Board of Directors of Doctors of the World – USA.
Dr Ward received medical training at McGill, University of London and Johns Hopkins (Tropical Medicine, Infectious Diseases, Microbiology). His research training began as a Rhodes scholar at Oxford (Quebec: Corpus Christie 1977) and continued at Johns Hopkins. He joined the Faculty of Medicine at McGill in 1991. He is currently professor of Medicine and Microbiology. He is also associate director of the JD MacLean Centre for Tropical Diseases, co-director of the McGill Vaccine Study Centre and medical director of the National Reference Laboratory for Parasitology.
Since late 2010, he has served as the Medical Officer for Medicago Inc, a company in Quebec City using plants to make vaccines. His research interests include micronutrient-virus interactions, nanoparticle vaccines, parasite diagnostics and HIV transmission. He has published over 225 peer-reviewed manuscripts and chapters and was recently elected to the Canadian Academy of Health Sciences. His international research has been carried out with colleagues in Peru, Zimbabwe, Sudan, Haiti, Thailand and Venezuela among other countries.
VENUE AND REGISTRATION
HOW TO REGISTER
Online registration, on Québec International web site, is the easiest registration method available to you.
You will automatically receive an email confirmation.
An invoice will be sent to you by email in the next following day.
Registration rates of 450 CAD$ (GST not included) are for the entire meeting (registrations includes, all session and lunches October 18th & 19h and the symposium Dinner on the evening of the 18th).
Name badge will be delivered when arriving on site. Site will open at 7:45 am October Wednesday 18th.
The conference will be held at Hotel Chateau Laurier in Québec.
Accommodation reservations should be made directly with the hotel. Special conference rate starting at 178 CAD$* have been arranged for delegates.
*Prices are per room, per night, quoted in CAD$, do not include GST
AIRLINE TICKETS TO QUÉBEC CITY
Québec International and Air Canada have entered into an agreement under which participants in major events will qualify for a discount on airline tickets to Quebec City (subject to certain conditions).
If you would like to purchase a ticket, please use the following code: C82EQ341
Tickets must be reserved directly on Air Canada's website.
The reservation destination must be Québec City, Québec (YQB).
Travel must take place between Tuesday, October 10th, 2017 and Friday, October 27, 2017.
No price reductions will apply to Tango-fare reservations for travel in Canada or between Canada and the US.